Multiple other proteins are known to be deregulated in many cancer types that support metastases for example deregulation of phosphoglycerate dehydrogenase (PHGDH),52 α‐ketoglutarate,53 monocarboxylate transporter 1 (MCT1),54 pentose phosphate pathway,55 acetyl‐CoA carboxylase (ACC)56 etc. Decoding these metabolic pathways and their role in metastatic can be beneficial in designing new targeted therapies against metastatic cancer types. Here, SLC16A1 is linked to metastatic malignant neoplasm.